IL25 and colorectal carcinoma: However, in another study, direct neutralization of IL-25 with a mAB in a chemically induced inflammatory model of CRC supports tumor progression [74], suggesting that the response to IL-25 therapy would likely be heavily dependent on the characteristics of the patient's TME.